Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

UBE4A Recombinant Antibody


Bioss logo
View Antibody details

UBE4B Recombinant Antibody


Bioss logo
View Antibody details

UBF1 Recombinant Antibody


Bioss logo
View Antibody details

Ubiquitin D Recombinant Antibody


Bioss logo
View Antibody details

Ubiquitin Recombinant Antibody


Bioss logo
View Antibody details

Ubiquitin specific peptidase 13 Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Ubiquitin Specific Peptidase 14 Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Ubiquitin Specific Peptidase 5 Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Ubiquitin specific peptidase 7 Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details

Ubiquitination Factor E4B Recombinant Antbody Kit (KD-Validated)


Bioss logo
View Antibody details